- Clinical evaluation of Himplasia in the management of benign prostate hyperplasia.
Vijay N. Agarwal, M.D., M.C.h. (Urol), Ex-Associate Professor Urology, Government Medical College, Surat, Gujrat, India,
Priyanka Agarwal, M.S., Consultant Surgeon, Surat, Gujrat, India,
Pralhad S. Patki, M.D., Head-Medical Services & Clinical Trials, R&D Center, The Himalaya Drug Company, Bangalore, India.
Indian Medical Journal, 2010; 104(1): 20
- Evaluation
of clinical efficacy and safety of Himplasia in BPH: A prospective, randomized,
placebo-controlled, double blind, phase III clinical trial
Dr. Pranjal R. Modi1, DNB (Urology) and Dr. S.A.
Kolhapure2*, MD. 1Department of Urology and Transplantation Surgery,
Institute of Kidney Diseases & Research Centre, BJ Medical College & Civil Hospital,
Ahmedabad, India, 2Senior Medical Advisor, R&D Center, The Himalaya Drug Company,
Bangalore, India, Medicine Update 2004: 12(6), 33.
- Evaluation
of the efficacy and safety of Himplasia in BPH: A randomised, double-blind, placebo-controlled, phase
III clinical trial
Dr. Saswata Chakraborty, M.S.1, Dr. Dilip Karamakar, M.S., M.Ch.2,
Dr. S.A. Kolhapure, M.D.,3* 1Research Assistant, 2Professor & Head,
Department of Urology, Calcutta National Medical College & Hospital, Kolkata, India.
3Senior Medical Advisor, R&D Center, The Himalaya Drug Company, Bangalore,
India, Medicine Update (2004): 12(4), 39.
- Evaluating
the Efficacy and Safety of Himplasia (PC-27) in the Medical Management of Benign
Prostatic Hyperplasia
Ketan Shukla, Consultant Urologist & Transplant Surgeon,
Sterling Hospital, Behind Drive-in Cinema, Ahmedabad, India, and Kolhapure, S.A.,
R&D Center, The Himalaya Drug Company, Bangalore, Karnataka, India, Indian Journal of Clinical Practice (2004): April issue.
- Clinical
evaluation of Himplasia in benign prostatic hyperplasia: An open
clinical trial
Manoranjan Sahu, Ramesh Bhat, P., Department of Shalya Shalakya, Sir
Sundarlal Hospital, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh,
India, and Kala Suhas Kulkarni, R&D Center, The Himalaya Drug Company, Bangalore, India,
Medicine Update (2003): (11), 1, 75.
-
Double-blind placebo-controlled study of PR-2000 in the management
of benign prostatic hyperplasia
Garg, S.K., M.S., D.N.B. (Surgery), M.Ch.,
D.N.B. (Urology) Bombay, Urologist and Transplant Surgeon, Garg
Urological Clinic, B-51, Brij Enclave Colony, Varanasi-221 005,
Uttar Pradesh, India, and
Kala Suhas Kulkarni*, M.D., Medical Advisor, R&D Center, The
Himalaya Drug Company, Makali, Bangalore, India, The Antiseptic
(2002): (99), 1, 8.
-
Use of PR-2000, a herbal formulation in the medical management
of benign prostatic hyperplasia
Shukla, G.N., Medical Superintendent &
Professor of Surgery, C.U. Shah Medical College, Dudhrej Road,
Surendranagar-363 001. Gujarat, India, and Mahender Nayak, Senior
Executive - R&D Center, The Himalaya Drug Company, Bangalore,
India, Indian Journal of Clinical Practice (2002): (13), 2, 53.
-
A study of Prostane in the treatment of benign prostatic hyperplasia
Lokesh Upadhyay and Tripathi, K., Department
of Medicine, Institute of Medical Sciences, Banaras Hindu University,
Varanasi, Uttar Pradesh, India, Phytotherapy
Research (2001): (15), 411.
-
Efficacy and safety of a herbal preparation PR-2000 in the treatment
of symptomatic benign prostatic hyperplasia
Sahu, M., Reader and Head, Department
of Shalaya Shalakya, Institute of Medical Sciences, Banaras Hindu
University, Varanasi, Uttar Pradesh, India,
and Vijay Kumar, V., M.B.B.S., Clinical Research Associate, R&D
Center, The Himalaya Drug Company, Makali, Bangalore, India, JAMA
India - The Physicians' Update (2001): 4 (12), 43.
-
Efficacy and safety of 'Prostane' in the management of symptomatic
benign prostatic hyperplasia: A clinical evaluation
Singh, K.M., M.S., F.I.C.S., F.A.C.S.,
M.N.M.S., Head, Department of Urology, King George's Medical College,
Lucknow, India, JAMA India - The Physicians' Update (2001): (4),
11, 43.
|
 |
